Ginkgo biloba for cognitive impairment and dementia (Q24245535)

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

A double-blind, placebo controlled study of Ginkgo biloba extract ('tanakan') in elderly outpatients with mild to moderate memory impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

Efficacy of Ginkgo biloba in 90 outpatients with cerebral insufficiency caused by old age Results of a placebo-controlled double-blind trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

Ginkgo biloba for cerebral insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

A new rating scale for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

Development and validation of the geriatric evaluation by relatives rating instrument (GERRI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

A new scale for clinical assessment in geriatric populations: Sandoz Clinical Assessment--Geriatric (SCAG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

7 January 2021

The effects of acute doses of standardized Ginkgo biloba extract on memory and psychomotor performance in volunteers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

7 January 2021

[Delay in progression of dependency and need of care of dementia patients treated with Ginkgo special extract EGb 761].

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

7 January 2021

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

1 reference

7 January 2021

Interaction between psychological and pharmacological treatment in cognitive impairment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

7 January 2021

Clinical efficacy of Ginkgo biloba special extract EGb 761 in dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

7 January 2021

Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

7 January 2021

Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

7 January 2021

Cognitive psychophysiology in nootropic drug research: effects of Ginkgo biloba on event-related potentials (P300) in age-associated memory impairment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

7 January 2021

Spontaneous hyphema associated with ingestion of Ginkgo biloba extract

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

7 January 2021

Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

7 January 2021

Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

7 January 2021

A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

7 January 2021

Influence of the severity of cognitive impairment on the effect of the Gnkgo biloba extract EGb 761 in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

7 January 2021

The Gottfries-Bråne-Steen scale: validity, reliability and application in anti-dementia drug trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

7 January 2021

Therapeutic value of Ginkgo biloba in reducing symptoms of decline in mental function

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

7 January 2021

Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

7 January 2021

A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer's type.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003120.PUB2

7 January 2021

10.1002/14651858.CD003120.PUB2

Identifiers

DOI

0 references

Fatcat ID

release_434olmuws5bevlrty5cn47wthu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/434olmuws5bevlrty5cn47wthu

24 November 2022